Inner Mongolia Furui Medical Science Co Ltd. Stock Analysis 300049.SZ

Inner Mongolia Furui Medical Science Co., Ltd. engages in the provision of disease diagnosis, drug treatment, and chronic disease management services for liver disease. The company is headquartered in Beijing, Beijing and currently employs 946 full-time employees. The company went IPO on 2010-01-20. The firm operates its businesses through three segments. The Pharmaceuticals and Services segment is mainly engaged in the production and sales of Compound Biejia Soft Liver Tablets and managed medical services. The Equipment and Technology segment is mainly engaged in the research and development and sales of the FibroScan series of liver fibrosis diagnostic instruments. The Overseas Investment and Management segment is mainly engaged in related investment and management businesses. The firm mainly operates its businesses in the domestic and overseas markets.